Pathology Progression Phases
Infection Window
Pathogen replicates inside body tissue (e.g. liver for malaria, blood cells for dengue). Usually asymptomatic during this window.
Clinical Manifestation
Sudden onset of high fever, severe headache, muscle joints pain, and shivering. Highly infectious to feeding vectors.
Convalescence or Crisis
Antibodies clear the pathogen. If complications develop (e.g. plasma leakage, hemorrhagic shock), intensive care is required.
Epidemiology
Yellow fever is caused by the yellow fever virus, a member of the Flaviviridae family. It remains endemic in tropical areas of Africa and Central/South America. Urban outbreaks occur when infected travelers introduce the virus to crowded cities with high Aedes aegypti populations.
Phases of Infection
The disease progresses in two phases: the acute phase (fever, muscle pain, vomiting) which lasts 3 to 4 days, followed by a brief remission. While most recover, about 15% enter a toxic phase where jaundice develops, bleeding begins, and multi-organ failure can occur, resulting in a 20-50% fatality rate.
Diagnostic Symptoms Checklist
- Sudden onset of fever
- Chills
- Severe headache
- Back pain and generalized muscle aches
- Nausea and vomiting
- Jaundice (yellow skin and eyes)
- Hemorrhagic symptoms (bleeding from nose, mouth, eyes, or stomach)
Risk Factors
- •Travelers visiting jungle or savanna areas in endemic zones.
- •Unvaccinated populations in African and South American tropical zones.
Treatment Protocol
There is no cure or specific drug treatment for yellow fever. Treatment is entirely supportive and symptomatic, managing dehydration, fever, and secondary bacterial infections.
Frequently Asked Questions
Is the yellow fever vaccine lifelong?
Yes, a single dose of the yellow fever vaccine provides lifelong protection for most individuals, and booster doses are no longer required for international travel under WHO regulations.